tiprankstipranks
Trending News
More News >
Ihuman Inc. (IH)
:IH
US Market

iHuman (IH) Price & Analysis

Compare
84 Followers

IH Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.26%99.74%
Insiders
0.26% Other Institutional Investors
99.74% Public Companies and
Individual Investors

IH FAQ

What was Ihuman Inc.’s price range in the past 12 months?
Ihuman Inc. lowest stock price was $1.47 and its highest was $3.18 in the past 12 months.
    What is Ihuman Inc.’s market cap?
    Ihuman Inc.’s market cap is $120.16M.
      When is Ihuman Inc.’s upcoming earnings report date?
      Ihuman Inc.’s upcoming earnings report date is Jun 18, 2025 which is 2 days ago.
        How were Ihuman Inc.’s earnings last quarter?
        Ihuman Inc. released its earnings results on Mar 25, 2025. The company reported $0.068 earnings per share for the quarter, beating the consensus estimate of N/A by $0.068.
          Is Ihuman Inc. overvalued?
          According to Wall Street analysts Ihuman Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Ihuman Inc. pay dividends?
            Ihuman Inc. pays a Annually dividend of $0.085 which represents an annual dividend yield of 3.68%. See more information on Ihuman Inc. dividends here
              What is Ihuman Inc.’s EPS estimate?
              Ihuman Inc.’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Ihuman Inc. have?
              Ihuman Inc. has 22,721,579 shares outstanding.
                What happened to Ihuman Inc.’s price movement after its last earnings report?
                Ihuman Inc. reported an EPS of $0.068 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
                  Which hedge fund is a major shareholder of Ihuman Inc.?
                  Currently, no hedge funds are holding shares in IH

                  iHuman Stock Smart Score

                  5
                  Neutral
                  1
                  2
                  3
                  4
                  5
                  6
                  7
                  8
                  9
                  10

                  Technicals

                  SMA
                  Positive
                  20 days / 200 days
                  Momentum
                  29.92%
                  12-Months-Change

                  Fundamentals

                  Return on Equity
                  10.27%
                  Trailing 12-Months
                  Asset Growth
                  -4.90%
                  Trailing 12-Months

                  Company Description

                  Ihuman Inc.

                  iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China. The company offers interactive and self-directed learning apps, including iHuman Chinese, iHuman ABC, iHuman Pinyin, iHuman Magic Thinking, iHuman Books, iHuman Stories, iHuman Reading, iHumanpedia, iHuman Kids Workout, iHuman Coding, iHuman Fun Idioms, iHuman Little Artists, and iHuman Readers. It also provides intellectually stimulating materials, including books, interactive materials, and smart devices that develop children's abilities in speaking, critical thinking, independent reading, and creativity. The company was founded in 1996 and is based in Beijing, the People's Republic of China.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Enanta Pharmaceuticals
                  Alector
                  American Well
                  C4 Therapeutics
                  Elicio Therapeutics
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis